Agenda
Applications for consideration at this meeting
- 1595.1 Closed loop upper airway stimulation for moderate to severe obstructive sleep apnoea, in patients who have failed or are intolerant to, continuous positive airway pressure therapy
- 1627 Point-of-care testing for sexually transmitted infections provided by Aboriginal Medical Services or Aboriginal Community Controlled Heath Services in rural or remote areas
- 1637 Expanded Reproductive Carrier Screening of couples for joint carrier status of genes associated with autosomal recessive and X-linked conditions
- 1658 Testing of tumour tissue to determine a positive homologous recombination deficiency status in women newly diagnosed with advanced (FIGO stage III-IV) high grade epithelial ovarian, fallopian tube or primary peritoneal cancer for access to PBS olaparib
- 1666 Exclusion of the left atrial appendage via surgical epicardial clip implantation concomitant to open cardiac surgery for patients with atrial fibrillation
- 1668 Whole body magnetic resonance imaging for detection of cancer in individuals with germline pathogenic TP53 variants
- 1669 KRAS G12C variant testing to determine eligibility for PBS-subsidised sotorasib second-line therapy in patients with locally advanced or metastatic non small cell lung cancer
- 1671 Targeted carrier testing for severe monogenic conditions
- 1672 Procedures for the insertion or removal of a leadless permanent pacemaker for the treatment of bradyarrhythmia
- 1673 Single operator, single use, peroral cholangiopancreatoscopy for diagnosis of indeterminate biliary strictures and removal of difficult biliary stones
- 1674 Testing for mismatch repair deficiency (dMMR) in endometrial cancer to help determine eligibility for PBS-subsidised dostarlimab
Related information
Committee: